Adavosertib is a small molecule inhibitor of the kinase enzyme WEE1, under investigation as an experimental anti-cancer drug candidate. It is a compound used in pharmaceutical research and development.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Adavosertib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
4-Hydroxy-2,2-diphenylbutyric acid gamma-lactone
pharmaceutical raw material
2H-Pyrazolo[3,4-b]pyridine-3-carbonitrile
pharmaceutical raw material
Apalutamide
pharmaceutical raw material
Ranolazine
pharmaceutical raw material
The international HS code for Adavosertib (CAS 955365-80-7) is 2933.59.
2933.59
2933 59 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
1-[6-(2-hydroxypropan-2-yl)-2-pyridinyl]-6-[4-(4-methylpiperazin-1-yl)anilino]-2-prop-2-enylpyrazolo[3,4-d]pyrimidin-3-one
BKWJAKQVGHWELA-UHFFFAOYSA-N
CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O
Sourcing Adavosertib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.